Skip to content

Clinical trials

Phase 1/2 Autistic Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autistic Disorder Phase: Phase 1/2 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20051
20062
20081
20093
20121
20142
20161
20171
20181
20192
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Unknown status4
Not yet recruiting3
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2
State-Financed Health Facility "Samara Regional Medical Center Dinasty"2
Ageless Regenerative Institute1
Black Tie Medical, Inc.1
Boston Children's Hospital1
Chaitanya Hospital, Pune1
Chang Gung Memorial Hospital1
Children's Hospital Medical Center, Cincinnati1
Chugani, Diane C.1
Federal University of São Paulo1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autistic Disorder24
Autism Spectrum Disorder8
Asperger Syndrome3
Child Development Disorders, Pervasive3
Intellectual Disability2
Learning Disabilities2
Anxiety Disorders1
Cognition Disorders1
Cognitive Dysfunction1
Food Hypersensitivity1

Trials

Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.